文献速递母胎医学

抗Ro/SSA抗体暴露胎儿中不伴房室传导阻滞的心内膜弹力纤维增生症模式

Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

该研究纳入来自四个心脏中心的11例就诊时表现为孤立性心内膜弹力纤维增生症(EFE)的胎儿,由胎儿心脏病专家对超声心动图EFE位置达成共识。10例存在主动脉根/近端主动脉和/或左室流出道EFE,同10例存在肺动脉根/肺动脉和/或右室流出道EFE。就诊时房室间期均正常,1例后续出现房室传导阻滞;9例经胎盘地塞米松治疗,5例加用静脉注射免疫球蛋白,1例仅用免疫球蛋白;10例治疗者中6例EFE改善、4例严重程度不变;全部活产。

要点

  • 抗Ro/SSA抗体暴露胎儿可不伴房室传导阻滞而表现为EFE,主动脉和肺动脉及流出道EFE几乎普遍存在。
  • 11例中10例有主动脉根/近端主动脉和/或左室流出道EFE,同10例有肺动脉根/肺动脉和/或右室流出道EFE,6例心房EFE、6例心十字EFE。
  • 就诊时房室间期均正常,1例后续发生房室传导阻滞;全部活产。

核心结论

  • 在该队列中,主动脉和肺动脉及流出道的EFE几乎普遍存在,心房和心十字受累也常见。
  • 高存活率和低房室传导阻滞负担提示,抗Ro/SSA抗体介导的心脏病中存在一种预后良好的独特表型。

研究设计与样本

  • 来自四个心脏中心的11例就诊时表现为孤立性EFE的胎儿被纳入。
  • 由经验丰富的胎儿心脏病专家对就诊时超声心动图EFE位置达成共识。
  • 评估后续胎儿和出生后超声心动图的间期变化以评价治疗反应。
  • 回顾心脏性能的超声心动图标志物,包括舒张功能和房室传导。

主要发现

  • 10例胎儿存在主动脉根、近端主动脉和/或左室流出道EFE。
  • 同10例中,识别出肺动脉根、肺动脉和/或右室流出道EFE。
  • 6例存在心房EFE,6例存在心十字EFE。
  • 4例在诊断前已知抗Ro/SSA抗体阳性,其余7例因超声心动图发现而检测,均阳性。
  • 就诊时所有病例房室间期正常,但1例胎儿后续发生房室传导阻滞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Anti-Ro/SSA-antibody-mediated endocardial fibroelastosis (EFE) without atrioventricular (AV) block at presentation is a rare cardiac phenotype. We report on 11 fetuses with this rare type of anti-Ro/SSA-antibody-mediated cardiac involvement, presenting with a distinctive echocardiographic pattern of EFE. Eleven fetuses with isolated EFE at presentation were included from four cardiac centers, and experienced fetal cardiologists reached a consensus regarding EFE location on echocardiography at presentation. Interval changes to subsequent fetal and postnatal echocardiograms were assessed to evaluate response to therapy. Echocardiographic markers of cardiac performance, including diastolic function and AV conduction, were reviewed. Ten fetuses were found to have EFE of the aortic root, proximal aorta and/or left ventricular outflow tract. In the same 10 cases, EFE of the pulmonary root, pulmonary artery and/or right ventricular outflow tract was identified. Six cases had atrial EFE and six had EFE of the crux. Four cases were known to be positive for anti-Ro/SSA antibodies prior to diagnosis, whereas, in the remaining seven, echocardiographic findings prompted testing, which was positive in all cases. The AV interval at presentation was normal in all cases, but one fetus subsequently developed AV block. Nine patients were treated with transplacental dexamethasone, five of which also received intravenous immunoglobulin (IVIG), and one received IVIG only. Of the 10 treated cases, six had improvement in EFE as shown by serial imaging and, in four cases, the severity was unchanged. All patients were liveborn. In our cohort, EFE of the aortic and pulmonary arteries and outflow tracts was nearly universal, and involvement of the atria and the crux of the heart was also common. The high survival rate and low burden of AV block are also suggestive of a distinct phenotype of anti-Ro/SSA-antibody-mediated cardiac disease with a favorable prognosis. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Keller SB, Cohen J, Moon-Grady A, et al. Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies. Ultrasound Obstet Gynecol. 2023. PMID: 36806323. doi:10.1002/uog.26181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。